5 Best Stocks to Buy According to Billionaire Paul Tudor Jones

3. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Value: $80.70 million
Shares: 527,741
Percentage of 13F Portfolio: 1.61%

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) is a developer of therapeutic products and it ranks 3rd on our list of the best stocks to buy according to billionaire Paul Tudor Jones. The company has a collaboration and license agreement with Halozyme Therapeutics, Inc. as well.

In May, 2o21, Alexion Pharmaceuticals, Inc.’s (NASDAQ:ALXN) shareholders voted to have the company be acquired by AstraZeneca, a deal that is expected to be completed by the third quarter of this year. As for the company’s first-quarter report, its non-GAAP EPS of $3.52 beat the $3.14 estimate in Q1, and its revenue stood at $1.64 billion. The revenue represents an 18.24% growth year over year, and it also announced a gross profit margin of 90.94%. Alexion Pharmaceuticals, Inc.’s (NASDAQ: ALXN) gained 14.32% in the past 6 months and 15.14% year to date.

By the end of the first quarter of 2021, there were 77 hedge funds tracked by Insider Monkey, that held stakes in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) with a total value of $6.92 billion. Comparatively, in the previous quarter, there were 77 hedge funds with stakes in the company worth roughly $6.02 billion.

Here’s what ClearBridge Investments said about Alexion Pharmaceuticals, Inc.’s (NASDAQ: ALXN) in its first-quarter 2021 investor letter:

“We also sold biotechnology holding Alexion Pharmaceuticals ahead of its acquisition by AstraZeneca but expect to redouble our efforts in health care through the rest of the year. We see good growth potential in the sector and after full due diligence, have been busy populating our wish list with new names we would like to own.”